Defining candidate drug characteristics for Long-QT (LQT3) syndrome (Q1942492): Difference between revisions
From MaRDI portal
Removed claims |
Changed an Item |
||
| Property / author | |||
| Property / author: Glenn Terje Lines / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Andrew D. McCulloch / rank | |||
Normal rank | |||
Revision as of 03:11, 11 February 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Defining candidate drug characteristics for Long-QT (LQT3) syndrome |
scientific article |
Statements
Defining candidate drug characteristics for Long-QT (LQT3) syndrome (English)
0 references
19 March 2013
0 references
cardiac arrhythmias
0 references
drug design
0 references
Markov models
0 references
optimization
0 references
